PATENT CLAIM ANALYSIS

Application Number: 15767795
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "248000"]

Abstract:
The present invention provides compounds of Formula I: wherein Y, AA, W, R 3′  R 2 , R 4 , R 5 , R 6 , R 7 , X 1 , X 2 , X 3 , X 4  and X 5  are as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt, prodrug or esters or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments for treating or preventing thromboembolic disorders.

Claim (Index 7):
The compound of  claim 1 , wherein Y is S.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 91.0
- Lexical Diversity: 1.71186
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15549307', '15549257', '14396831', '15593534', '14396807']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8271589841742631
- 35 USC 102 Novelty (BERT): 0.5531005110406328
- Combined Prediction Score: 0.7997531368609001
- Mean Citation Score: 404.92014600000016
- Max Citation Score: 412.2366
- Similarity Product: 388.4789122876525

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test